Brian Casey and Wayne Forrest[email protected]Clinical NewsPull linear MRI contrast from market, European group saysIn a stunning development, a European Union regulatory body on Friday recommended that four gadolinium-based contrast agents for MRI scans be pulled off the market due to concerns about gadolinium remaining in the body years after scans occur. The agents affected include some of the most widely used contrast products in medical imaging.March 9, 2017Page 1 of 1Top StoriesCTThe epidemic of decision paralysisDecision-making is central to successful clinical practice, but no one seems to make decisions these days, writes Dr. Paul McCoubrie in the second part of his series about interactions between surgeons and radiologists.CTGlobal survey pinpoints key trends in spectral CTCTAbnormal CT-FFR results translate to up to 7 years' cardiac riskWomens ImagingTransgender breast care emerges as priority for radiologyOrganized Radiology IssuesHot shots from Istanbul: Report from ESNR 2025